Dr. William Kim

Biography

William Kim demonstrated a passion for interdisciplinary collaboration. His research leverages advanced computational data-driven approaches alongside genome engineering technologies to contribute to advancing the understanding of cancer. Kim received his PhD from Duke University in the Institute of Genome Sciences and Policy, receiving support from the Department of Defense Breast Cancer Research Predoctoral Program and the Korean Science & Engineering Foundation Award. During his doctoral work, Kim joined the Dana Farber Cancer Institute and the Broad Institute of Harvard and MIT for postdoctoral research, making significant contributions to developing novel computational approaches for systematic characterization of cancer genomes and oncogenic cellular states. He discovered a novel role for the Protein phosphatase 2A (PP2A) enzyme in oncogenic transformation, expanding the understanding of this important signaling pathway. Leveraging his expertise in cancer biology and computational biology, Kim joined the University of California San Diego (UCSD) School of Medicine in the Division of Genomics and Precision Medicine, where he co-led a multidisciplinary team for the California Initiative Precision Medicine Project. He served as Co-Director of the UCSD Center for Cancer Target Discovery Development (CTD2), driving the integration of data-driven biological approaches in cancer research. Currently, at Yale University School of Medicine's Department of Urology, Kim aims to bridge the gap between cancer biology and data science, working towards a comprehensive understanding of cellular circuitry to realize the full potential of cancer precision medicine.

Research Interests